We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Olympus America Acquires Bacus Labs

By Labmedica staff writers
Posted on 27 Jul 2006
Olympus America Inc. More...
(Melville, NY, USA), a precision technology company that designs imaging systems for use in healthcare and life sciences, has acquired privately-owned Bacus Laboratories, Inc. (BLI, Lombard, IL, USA). BLI will retain its name, and all employees will retain their positions. Licenses and other business relationships will remain mostly unaffected. Financial details were not disclosed.

By securing BLI's patents and capabilities as part of the transaction, Olympus has gained access to two key technologies, virtual microscope slide and telemedicine, enabling the company to offer a one-step solution to companies seeking a virtual microscope slide system. Virtual slides allow professionals to review biopsies and other pathology images without handling traditional glass slides. Using telemedicine, doctors can share highly detailed microscope slide images over the internet for long-distance consultation.

Among the products to be sold by the combined company is the Bliss system, designed for a single workstation, which is a combination of an Olympus microscope with BLI software. BLI also provides virtual microscope slides and internet software for medical education.

More than 60% of professional decisions made by physicians are influenced by medical testing. Medical slides contain so much high-resolution data that it can take thousands of typical digital pictures to reproduce all the data in one image, and require powerful computers to store the data. The combination of Olympus and BLI technologies can help streamline the process, save substantial expense, and enhance patient care.

Dr, Stephen S. Tang, group vice president and general manager of Life Science, Olympus America, said "Being able to digitize slides and share analysis, and attach images to a patient's file is the step we have been waiting for. It paves the way to more informed decisions by physicians, better-served patients, and enhanced teaching and training.”





Related Links:
Olympus America
Bacus Laboratories

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Rapid Sepsis Test
SeptiCyte RAPID
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.